Author profile
Department of Radiation Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School
To investigate whether the apparent diffusion coefficient (ADC) from diffusion-weighted imaging (DWI) acquired at a 0.35T MR-Linac can determine prostate and intraprostatic lesion changes caused by adaptive radiotherapy performed on this treatment modality.
We compared denoising methods for Diffusion-Weighted Imaging (DWI) of phantoms acquired on a low-field MR-Linac to determine which method best preserves Apparent Diffusion Coefficient (ADC) accuracy and image feature detection. Our goal was to quantify image...
To clinically implement and evaluate an MRI-only treatment planning (MRTP) workflow for interstitial high-dose-rate (HDR) brachytherapy in gynecologic cancers. In contrast to the conventional CT/MRI-based planning (CTP) approach, MRTP eliminates CT imaging, t...
Adaptive MR-guided Stereotactic Body Radiation Therapy (MRg-SBRT) is an effective treatment for malignant pancreatic lesions. However, its implementation may be hindered by the presence of implants with scanning conditions interdicting body coil transmission...
The efficacy of stereotactic radiosurgery (SRS) and radiotherapy (SRT) for brain metastases is often compromised by tumor growth and soft tissue changes between simulation and treatment. To eliminate these latencies, we clinically implemented a novel same-day...